Cargando…
Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
We hypothesized that women inheriting one germline mutation of the BRCA1 gene (“one-hit”) undergo cell-type-specific metabolic reprogramming that supports the high biosynthetic requirements of breast epithelial cells to progress to a fully malignant phenotype. Targeted metabolomic analysis was perfo...
Autores principales: | Cuyàs, Elisabet, Fernández-Arroyo, Salvador, Alarcón, Tomás, Lupu, Ruth, Joven, Jorge, Menendez, Javier A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288162/ https://www.ncbi.nlm.nih.gov/pubmed/27259235 http://dx.doi.org/10.18632/oncotarget.9732 |
Ejemplares similares
-
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017) -
Activation of the methylation cycle in cells reprogrammed into a stem cell-like state
por: Fernández-Arroyo, Salvador, et al.
Publicado: (2016) -
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010) -
Oncometabolic Nuclear Reprogramming of Cancer Stemness
por: Menendez, Javier A., et al.
Publicado: (2016) -
Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers
por: Kumar, Nagi B., et al.
Publicado: (2012)